Galapagos spinout Coultreon raises $125M for new take on SIK inhibition
Coultreon Biopharma has patched together $125 million from some of the largest biotech investors in the US and Europe in a bid to join the burgeoning pipeline-in-a-pill approach to autoimmune diseases. The Tuesday morning Series ...
ORIGINAL SOURCE →via Endpoint News
ADVERTISEMENT
⚡ STAY AHEAD
Events like this, convergence-verified across 689 sources, land in your inbox every Sunday. Free.
GET THE SUNDAY BRIEFING →RELATED · energy
- [ENERGY] Two Nuclear Wrongs Don’t Make a Right
- [ENERGY] Economist Shaul Meridor joins Eisenkot's Yashar! Party
- [ENERGY] Scientists learn how much baby stars in Orion weigh — by watching their dance moves
- [ENERGY] Oil and gas: how obsolescence management can save you millions of pounds
- [ENERGY] Drone debris sparks fire at Russian oil refinery, prompting evacuation of nearby residents
- [ENERGY] Why are stocks at highs with Hormuz closed and oil elevated?